Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Actin-related protein 8 (ACTR8, ARP8) is a critical subunit of the evolutionary conserved INO80 chromatin remodeling complex. It contains unique insertions in its actin fold that prevent it from forming filaments, distinguishing it from cytoplasmic actin and ensuring specific recognition of nucleosomes and histone H3–H4 tetramers[1][3][4][5]. As part of the INO80 complex, ACTR8 acts as a nucleosome recognition module, regulating chromatin structure by coupling ATP hydrolysis to nucleosome sliding and repositioning, thereby impacting gene transcription, DNA replication, repair of double-strand breaks, and mitotic chromosome alignment[1][2][3][5]. ACTR8 exhibits low basal ATPase activity and tightly binds ATP, but its structure is locked in a conformation unsuitable for filament formation[3][4]. While ACTR8 is essential for INO80 function and, by extension, maintenance of genome integrity, there is currently no evidence that it serves as a common therapeutic target or biomarker for disease[5].
Not applicable (no known drugs directly target ACTR8)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Actin-related protein 8 (ACTR8).